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Insulin causes a translocation of glucose transporters from intracellular microsomes to the plasma mem- 
brane in adipocytes. To determine whether insulin has a similar effect in rat hindlimb muscles, we used glu- 
cose-inhibitable cytochalasin B binding to estimate the number of glucose transporters in membrane frac- 
tions from insulinized and control muscles. Insulin treatment caused an approx. 2-fold increase in cytocha- 
lasin B-binding sites in a plasma membrane fraction and an approx. 70% decrease incytochalasin B-binding 
sites in an intracellular membrane fraction. In order to detect his effect of insulin, it was necessary to devel- 
op a procedure for isolating a plasma membrane fraction and an intracellular membrane fraction that were 
not contaminated with sarcoplasmic reticulum. Our results show that, as in adipocytes, insulin stimulates 
translocation of glucose transporters from an intracellular membrane pool to the plasma membrane inhind- 
limb skeletal muscles. 
Glucose transport; Insulin action; (Skeletal muscle) 
1. INTRODUCTION 
Studies on adipocytes have shown that insulin 
causes translocation of glucose transporters from 
an intracellular pool into the plasma membrane 
[1-5]. This process is thought o play a major role 
in the stimulation of glucose transport by insulin 
[1-5]. Skeletal muscle is the major site of insulin- 
mediated glucose transport accounting for ~90% 
of insulin-stimulated glucose removal from the 
blood [6], while adipose tissue probably accounts 
for less than 5% of insulin-mediated glucose up- 
take [7,8]. The question of whether or not insulin 
also causes a translocation of glucose transporters 
from an intracellular pool into the plasma mem- 
brane in skeletal muscle is therefore of great in- 
terest. However, in contrast to the wealth of 
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information regarding the effect of insulin on the 
distribution of glucose transporters in adipocytes, 
there is a paucity of similar data on skeletal 
muscle. 
This lack of information is due to the technical 
difficulty in obtaining adequate separation of a 
plasma membrane fraction containing glucose 
transporters from an intracellular pool of 
'microsome' bound glucose transporters, largely 
because of heavy contamination with other mem- 
brane fractions, particularly the sarcoplasmic 
reticulum. To our knowledge, Wardzala and 
Jeanrenaud [9,10], who studied rat diaphragms in- 
cubated with insulin, are the only investigators to 
report that insulin causes translocation of glucose 
transporters from an intracellular pool to the 
plasma membrane in a skeletal muscle. That no 
report of a similar finding by other investigators 
has been published in the 6 years since their first 
paper [9] attests to the technical difficulties in- 
volved. 
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We tried to apply the methods of Wardzala and 
Jeanrenaud to rat hindlimb muscles, but despite 
much effort were unable to separate adequately the 
glucose transporter containing plasma membrane 
and microsomal fractions. We have, therefore, 
developed another procedure for isolating these 
fractions from sufficiently large quantities of 
skeletal muscle to allow cytochalasin B-binding 
studies over a range of concentrations. Using this 
procedure, we were able to show that perfusing rat 
hindlimb muscle with a high concentration of in- 
sulin results in an increase in D-glucose-protectable 
cytochalasin B-binding sites in the plasma mem- 
brane with a concomitant decrease in cytochalasin 
B-binding sites in an intracellular membrane 
fraction. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Cytochalasin B, cytochalasin E, D- and L- 
glucose, and gradient-grade sucrose were obtained 
from Sigma. Porcine insulin (Regular Iletin) was 
obtained from Eli Lilly. [3H]Cytochalasin B was 
from Amersham. 
2.2. Animals and perfused hindlimb preparation 
Male specific pathogen-free Sprague-Dawley 
rats weighing 250-350 g were obtained from Sasco 
(Omaha, NE) and maintained on a diet of Purina 
chow and water. After an overnight fast, the rats 
were anesthetized with sodium pentobarbital 
(50 mg/kg body wt). Surgical preparation of the 
hindquarter, with placement of catheters in the ab- 
dominal aorta and inferior vena cava, was per- 
formed as described by Ruderman et al. [11]. The 
perfusion apparatus and procedure have been 
described previously [12]. The perfusion medium 
consisted of Krebs-Henseleit bicarbonate buffer 
(pH 7.4) containing 4 g/100 ml of bovine serum 
albumin, 8 mM glucose, and 0 or 1000/zU/ml in- 
sulin. The perfusion medium was oxygenated [12], 
and both the perfusion medium and the rat hind- 
quarter preparation were maintained at 37°C. The 
hindlimbs were initially washed out with 50 ml of 
perfusion medium. A 20 min long flow-through 
perfusion at a flow rate of 20 ml/min was then 
begun; arterial and venous samples of perfusate 
were taken after 10 and 20 min. The arterio- 
venous glucose concentration differences and per- 
fusate flow rate were used to calculate the rate of 
glucose uptake. Glucose concentration was 
measured using a YSI model 23A glucose analyzer 
(Yellow Springs Instrument). Immediately after 
perfusion, the muscles of both hindlimbs were 
dissected out, trimmed of fat and connective tissue 
while kept on ice, and then frozen in liquid N2. 
Muscles were kept at -70°C until used for 
preparation of membranes. 
2.3. Membrane preparation 
Membrane isolation was carried out by a 
modification of three previously described pro- 
cedures for the isolation of skeletal [13] and 
smooth [14] muscle membranes. The final protocol 
is illustrated in detail in fig.1. Essential 
characteristics of this purification procedure are 
the use of a low setting during the Polytron 
homogenization, a large dilution factor and the in- 
clusion of NaN3 in the buffer solution (to prevent 
both bacterial growth and redistribution of glucose 
transporters, in a manner akin to KCN [15]). The 
final step in the purification consisted of a 16 h 
centrifugation on discontinuous ucrose gradients 
(25, 30 and 35% sucrose, w/w). Membranes were 
collected from each sucrose layer, washed by 
10-fold dilution in 10 mM NaHCO3/0.25 M 
sucrose, 5 mM NaN3 and recovered by high-speed 
centrifugation. Samples were immediately assayed 
for cytochalasin B binding. They were then stored 
at -20°C and used within a week for subsequent 
enzyme marker analysis. 5'-Nucleotidase activity 
was measured as in [16]. Sarcoplasmic reticulum 
CaZ+-dependent ATPase and sarcolemmal Mg z+- 
dependent ATPase activities were assayed ac- 
cording to Hidalgo et al. [17]. Phosphodiesterase I 
activity was measured as described [13]. 
D-Glucose-protectable binding of [3H]cyto- 
chalasin B was measured at equilibrium with the 
indicated concentrations of cytochalasin B in the 
presence of 5/zM cytochalasin E and 200 mM of 
either D- or L-glucose as described previously 
[13,18,19]. The membranes were separated from 
the incubation medium by rapid (2 s) filtration 
through GF/B Whatman filters as reported in 
[13,18,19] or by ultracentrifugation [1,19] as 
stated. Binding at each concentration of [3H]cyto- 
chalasin B was tested in triplicate in the presence of 
D- or L-glucose. D-Glucose-protectable inding of 
cytochalasin B is recognized as a confident 
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25-35 g rat skeletal muscle, minced 
diluted lg/10 ml in I0 mM NaH~O3/0.25 M sucrose, 5mM NaN 3 
homogenized by Polytron PT20 lx5 s, setting 4-5 
ugation 1,200 x g, 10 min 
Pellet Supe .matant 
Re-homogenized as abov~ 
| Centrifugation at1,200 x g, 10 min 
l Supemata~t " '~  Pellet 
Centrifu~.fion, 9 ,0~,  10 rain 
Supern~atant Pellet 
Centrifugation, 190,000 x g, 60 rain 
Supernatant Pellet (CRUDE MEMBRANES) 
Applied to sucrose gradient (25%, 30% and 35% w/w) 
Centrifugation, 150,000 xg, 16 h 
on 25% sucrose PLASMA MEMBRANES; on 35% sucrose INTRACELLULAR MEMBRANES 
Washed by dilution and centrifugation at190,000 x g, 60 rain 
Fig.1. Schematic representation f the isolation procedure for plasma membranes and intracellular membranes from 
the rat hindquarter muscles. 
measurement for the estimation of glucose 
transporters [20]. 
2.4. Statistics 
Student's t-test for unpaired observations was 
used to evaluate the significance of differences be- 
tween muscles treated with insulin and control 
muscles not treated with insulin. 
3. RESULTS AND DISCUSSION 
3.1. Effect of insulin on glucose uptake by rat 
hindlimb 
Perfusion of rat hindquarter preparations with 
medium containing 1000/~U/ml of insulin resulted 
in an approx. 5-fold increase in the rate of glucose 
uptake. The rate of glucose uptake with no insulin 
in the perfusion medium averaged 33.3 + 3.4/~mol 
glucose/10 min per hindquarter, compared to 
175 _+ 16/~mol/10 rain per hindquarter when the 
perfusate contained insulin (P < 0.001; values are 
means + SE for 15 rat hindquarter preparations 
per group). This approx. 5-fold increase in glucose 
uptake is close to the maximal insulin response at- 
tainable in the perfused rat hindquarter prepara- 
tion [21]. The control and insulinized muscles from 
the perfused hindlimbs were used for isolation of 
membranes. 
3.2. Membrane isolation and character&ation 
A crude membrane preparation was isolated 
from 25-35-g aliquots of control and insulinized 
rat hindlimb muscles according to the scheme 
outlined in fig.1. Separation of the muscle mem- 
brane fractions was performed using a discon- 
tinuous sucrose density gradient. On the basis of 
preliminary findings, the fractions floating on 25 
and 35°7o sucrose were used in the present study. 
As shown in table 1, the 25°7o sucrose fraction was 
enriched in the plasma membrane marker enzymes 
5'-nucleotidase and MgZ+-ATPase relative to the 
crude membrane fraction. In contrast, the 3507o 
sucrose fraction was relatively poor in 
5'-nucleotidase and Mg2+-ATPase activities. In 
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Table 1 
Enzyme activities of membranes from muscles of rat hindquarter muscles 
November 1987 
Fraction Protein, 5' -Nucleotidase Mg 2+-ATPase Ca2+-ATPase 
mg/fraction (nmol/min per (amol/min per (umol/min per 
(mg/g tissue) mg protein) mg protein) mg protein) 





54 + 6 63 + 7 81 _+ 9 64 +_ 7 1.0 +_ 0.20.9 +_ 0.1 0.35 +_ 0.11 0.45 + 0.19 
(1.69) (1.88) 
1.9 + 0.32.1 + 0.2 305 _+ 25 245 _+ 19 3.2 _+ 0.42.7 _+ 0.5 non- non- 
(0.06) (0.06) detectable detectable 
10.8_+ 2 11.1 + 2 74_+ 10 76_+ 11 1.2 + 0.21.2_+ 0.2 non- non- 
(0.34) (0.33) detectable detectable 
Results are means +_ SE of 5 independent membrane preparations, each performed with 25-35 g of tissue isolated 
from control and insulin-treated rats. The separate contributions of the MgZ+-ATPase and CaZ+-ATPase were 
assessed in parallel determinations containing Mg 2+, in the presence and absence of Ca 2+ (the latter in the 
presence of EGTA). Under the conditions of this assay, the MgZ+-ATPase corresponds to a surface membrane 
ATPase [17,18], and the CaZ+-ATPase corresponds to the sarcoplasmic reticulum ATPase, as shown in [17] 
some preparations the activity of a third plasma 
membrane marker enzyme, phosphodiesterase I, 
was also tested. The results indicated a 6-fold 
enrichment in this activity in the 25°70 sucrose frac- 
tion relative to the crude membranes, and a 
relative depletion in the 35°70 sucrose fraction (not 
shown). 
Sarcoplasmic reticulum CaZ+-ATPase activity 
was not detectable in either fraction. (The sar- 
coplasmic Ca 2+-ATPase activity was largely 
recovered in the pellet of the gradient.) This 
separation of sarcoplasmic reticulum from the 
membrane fractions under study is important, 
because in preliminary studies in which muscle was 
homogenized more vigorously (15 s at a Polytron 
setting of 6) there was abundant CaZ+-ATPase ac- 
tivity in the 35°70 sucrose fraction, and the effect of 
insulin on D-glucose-inhibitable cytochalasin B- 
binding sites (see below) was obscured. The key to 
prevention of contamination by sarcoplasmic 
reticulum appears to be the short duration and 
relatively low intensity of the Polytron 
homogenization i  a large volume. 
The data in table 1 suggest that the 25°70 sucrose 
fraction is enriched in plasma membranes, while 
the 35°70 fraction is depleted of plasma mem- 
branes. Furthermore, the 35°70 sucrose fraction is 
not sarcoplasmic reticulum; instead, this fraction 
may represent an intracellular organeile in skeletal 
muscle that, as in adipocytes, contains glucose 
transporters ( ee below). At present, there does not 
appear to be a specific marker, other than an 
insulin-induced decrease in cytochalasin B binding, 
for the intracellular membranes endowed with 
glucose transporters [5]. 
Interestingly, insulin treatment caused a small 
but consistent decrease in 5'-nucleotidase activity 
in the 25°7o sucrose membrane fraction, with no 
change in the 35°7o sucrose fraction (table 1). The 
biological significance of this finding remains to be 
determined. Neither the MgZ+-ATPase activity nor 
the protein yield was influenced by the insulin 
treatment. Freezing the muscles did not alter the 
distribution of marker enzymes or cytochalasin B- 
binding sites, as judged by parallel assays in mem- 
branes prepared simultaneously from fresh and 
frozen muscles. 
3.3. Cytochalasin B binding 
Membrane fractions for cytochalasin B-binding 
studies were prepared from insulinized and control 
rat hindlimb muscles in five separate xperiments. 
D-Glucose-protectable cytochalasin B binding to 
the 25 and 35°70 sucrose fractions was measured at 
three cytochalasin B concentrations. Fig.2A shows 
the effect of perfusion of the muscles with a high 
concentration of insulin on the distribution of D- 
glucose-inhibitable cytochalasin B-binding sites in 
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Fig.2. Effect of treatment of rat skeletal muscle with insulin on cytochalasin B binding to a plasma membrane fraction 
(A) and to an intracellular membrane fraction (B). The hindlimbs were perfused with (o )  or without (m) insulin for 
30 min, and the hindlimb muscles were used for preparation of the two membrane fractions (see sections 2,3 for details). 
Points are the means _+ SE for 5 muscle preparations. * Insulin treated vs control, P < 0.05. 
the membrane fractions. The 25°70 sucrose fraction 
f rom the insulin-treated muscles showed a signifi- 
cant increase in D-glucose-inhibitable cytochalasin 
B-binding sites per mg protein compared to the 
same fraction f rom control muscles. Since the 2507o 
sucrose fraction is enriched in plasma membranes,  
as reflected in the activity of  the marker enzymes 
5' -nucleot idase,  phosphodiesterase I and Mg 2+- 
ATPase,  this finding suggests that, as in 
adipocytes [5], insulin causes an increase in the 
number of  glucose transporters in the plasma 
membrane in skeletal muscle. In contrast, treat- 
ment of  skeletal muscle with insulin resulted in a 
significant decrease in D-glucose-inhibitable cyto- 
chalasin B binding to the membranes in the 35°7o 
sucrose fraction (presumably an intracellular mem-  
brane fraction) (fig.2B). 
Cytochalasin B binding was low but measurable 
in the crude membrane fraction. In contrast to the 
change in cytochalasin B binding in the 25 and 
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Table 2 
Specific activity and recovery of cytochalasin B binding to muscle 
membranes 
Fraction Specific activity Recovery 
(pmol bound/mg protein) (pmol bound/fraction) 
Control Insulin Control Insulin 
25°7o sucrose 0.79 + 0.36 1.63 _+ 0.16 1.63 + 0.81 3.34 _+ 0.34 
35°7o sucrose 0.80 + 0.09 0.22 _+ 0.15 8.38 + 1.38 2.47 + 1.67 
Data from cytochalasin B binding at 0.2/~M [3H]cytochalasin B. Results 
are means _+ SE of 5 independent preparations 
November 1987 
35°7o sucrose fractions caused by the insulin treat- 
ment, the crude membranes did not display a 
change in cytochalasin B binding (not shown). 
In two membrane preparations, cytochalasin B
binding was also measured by the equilibrium cen- 
trifugation method. The 25°7o sucrose fractions 
from control muscles gave a binding of 
1.26 pmol /mg protein, compared to 3.11 pmol /  
mg in the corresponding fractions from insulin- 
treated muscles. The 35°7o sucrose fraction from 
control muscles gave a binding of 1.72 pmol/mg, 
but only 0.89 pmol /mg protein in the correspon- 
ding fraction from insulin-treated muscles. 
Table 2 shows the D-glucose-inhibitable 
cytochalasin B-binding data obtained at 0.2/~M 
cytochalasin B (using the ultrafiltration method). 
The results are expressed both per mg protein and 
as the total amount of D-glucose-protectable 
cytochalasin B binding recovered in each fraction. 
When expressed as binding per mg membrane pro- 
tein, there was a 2-fold increase (P < 0.05) in 
cytochalasin B binding in the plasma membrane 
enriched, 25°7o sucrose fraction from the muscles 
treated with insulin relative to controls. In the 35o70 
sucrose fraction, presumably containing an in- 
tracellular membrane fraction from muscles per- 
fused with insulin, there was an approx. 70°70 
decrease (P < 0.01) in cytochalasin B binding (per 
mg protein) relative to the corresponding control 
fraction. When expressed as the total cytochalasin 
B binding recovered in each fraction, there was 
also a 2-fold increase (P < 0.05) in binding in the 
25% sucrose fraction from insulin-treated muscles 
vs that from control muscles. Conversely, there 
was a 70°7o decrease (P < 0.01) in total cytochalasin 
B binding in the 35°70 sucrose fraction from 
insulin-treated muscles relative to control muscles. 
The abundance and variety of membranous 
organelles in skeletal muscles make it very difficult 
to isolate a plasma membrane fraction and an in- 
tracellular glucose transporter-containing micro- 
somal fraction that are not heavily contaminated 
with other membrane fragments, particularly sar- 
coplasmic reticulum. As a consequence, the pre- 
sent results depend markedly on the procedure 
followed to isolate the membrane fractions. In- 
sulinized and control muscles howed comparable 
distributions and recoveries of marker enzymes for 
plasma membrane; indeed, if anything, in the 
plasma membrane fraction from insulin-treated 
muscle there was a decrease of 5'-nucleotidase ac- 
tivity, in contrast o the increase in cytochalasin B 
binding (tables 1,2). Hence, when viewed in the 
context of the information available on adipocytes 
[1-5], our results show that insulin stimulates the 
translocation of glucose transporters from an in- 
tracellular membranous organelle to the plasma 
membrane in skeletal muscle. This may underlie at 
least in part the concomitant stimulation by insulin 
of glucose uptake into rat hindquarter muscles. 
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